Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma☆
To access this article, please choose from the options below
☆ This work was supported by PHS grants CA 83130 (BM), UCHC GCRC grant MO1RR06192, CA129816 (JSE), and grants from the Dowling Foundation (BM), Samuel Waxman Foundation, and WM Keck Foundation (JSE) for the UCLA-CALTECH-CHLA-USC-UCONN consortium on translational Program in Engineered Immunity.
PII: S0738-081X(08)00196-X
doi:10.1016/j.clindermatol.2008.09.019
© 2009 Published by Elsevier Inc.
